Abstracts Archive - Page 1877 of 2425 - ACR Meeting Abstracts

Abstract Number: 2640 • 2014 ACR/ARHP Annual Meeting
Prevalence and Predictors of ECG Cardiovascular Abnormalities in Lupus Patients
Zahi Touma¹, Paula Harvey², Dafna D. Gladman³, Dominique Ibanez¹, Arthy Sabapathy³ and Murray B. Urowitz³, ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Cardiology, Women's College Hospital, Toronto, ON, Canada, ³University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Patients with lupus are at increased risk for cardiovascular disease. Previous studies on healthy adults showed that abnormalities detected on resting electrocardiography (ECG)…
Abstract Number: 2639 • 2014 ACR/ARHP Annual Meeting
Coronary-Artery Atherosclerosis in Males with Systemic Lupus Erythematosus
Juanita Romero-Díaz¹, Sergio Criales-Vera², Eric Kimura-Hayama², Roberto Ivan Acosta-Hernandez¹, Maricruz Dominguez-Quintana¹ and Jorge Sánchez-Guerrero³, ¹Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico, ²Radiology Department, Instituto Nacional de Cardiologia, Mexico City, Mexico, ³Rheumatology, Mount Sinai Hospital and University Health Network, Toronto Canada, Toronto, ON, Canada
Background/Purpose . Premature coronary-artery atherosclerosis is a major cause of morbidity and mortality in females with systemic lupus erythematosus (SLE), but little is known about the…
Abstract Number: 2638 • 2014 ACR/ARHP Annual Meeting
The Protective Effects of Statins for Thrombosis in Patients with Systemic Lupus Erythematosus Positive for Antiphospholipid Antibodies
Toshiyuki Watanabe, Kenji Oku, Olga Amengual, Eri Sugawara, Ryo Hisada, Kazumasa Ohmura, Tomoko Fukui, Sanae Shimamura, Ikuma Nakagawa, Atsushi Noguchi, Haruki Shida, Michihito Kono, Yuka Shimizu, Takashi Kurita, Toshiyuki Bohgaki, Tetsuya Horita, Shinsuke Yasuda and Tatsuya Atsumi, Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Background/Purpose: Thrombosis is one of the most frequent manifestations in patients with systemic lupus erythematosus (SLE). Although antiphospholipid antibodies (aPL) are well recognized risk factors…
Abstract Number: 2620 • 2014 ACR/ARHP Annual Meeting
Mortality and Survival in Systemic Lupus Erythematosus Patients: Trends in a Spanish Cohort from 1985 to 2013
Sergi Heredia¹, Javier Narváez², Andrea Zacarias¹, Milagros Ricse¹, Gloria Albert¹, Eulalia Armengol¹, Helena Borrell¹, Olga Capdevila³, Francesca Mitjavila³, Toni Rozadilla¹, Xavier Juanola⁴ and Joan Miquel Nolla¹, ¹Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ²Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, ³Internal Medicine, Hospital Universitario de Bellvitge, Barcelona, Spain, ⁴Rheumatology, University Hospital Bellvitge, Barcelona, Spain
Background/Purpose: To study the mortality, survival and causes of death in a Spanish cohort of patients with systemic lupus erythematosus (SLE) over a 28-year period…
Abstract Number: 2619 • 2014 ACR/ARHP Annual Meeting
Low Socioeconomic Status (SES) As Measured By Education Is (not) Associated with Worse Outcome in SLE: Data from the 1000 Canadian Faces of Lupus
Angela George¹, Christine Peschken², Earl Silverman³, Christian A. Pineau⁴, C Douglas Smith⁵, Hector Arbillaga⁶, Michel Zummer⁷, Ann Clarke⁸, Sasha Bernatsky⁹, Marie Hudson¹⁰, Carol A. Hitchon¹¹, Paul R. Fortin¹² and Janet E. Pope¹³, ¹Medicine/Rheumatology, University of Western Ontario, London, ON, Canada, ²Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ³Pediatrics/Rheumatology, Toronto Hospital for Sick Children, U of Toronto, Toronto, ON, Canada, ⁴Rheumatology, McGill University Health Center, Montreal, QC, Canada, ⁵The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, ⁶Medicine/Rheumatology, Lethbridge Rheumatology practice, Lethbridge, AB, Canada, ⁷Medicine/Rheumatology, U of Montreal, Montreal, QC, Canada, ⁸Medicine/Allergy, U of Calgary, Calgary, AB, Canada, ⁹Clinical Epidemiology, McGill UHC/RVH, Montreal, QC, Canada, ¹⁰Medicine/Rheumatology, McGill University, Montreal, QC, Canada, ¹¹Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ¹²Rheumatology, Laval University, Division of Rheumatology, Centre de Recherche du CHU de Québec and Department of Medicine, Quebec City, QC, Canada, ¹³St Joseph Health Care, London, ON, Canada
Background/Purpose: To determine whether socioeconomic status, as measured by education, impacts disease activity (measured by SLAM-2, SLEDAI-2K) or disease damage (measured by SLICC SDI) in…
Abstract Number: 2618 • 2014 ACR/ARHP Annual Meeting
Impact of Ustekinumab on Active Inflammation and Post-Inflammatory Structural Changes As Detected By Magnetic Resonance Imaging in Patients with Active Ankylosing Spondylitis: Results of a 28-Week, Prospective, Open-Label, Proof-of-Concept Study
Denis Poddubnyy¹, Kay-Geert Hermann¹, Johanna Callhoff², Joachim Listing² and Joachim Sieper¹, ¹Charité Universitätsmedizin Berlin, Berlin, Germany, ²German Rheumatism Research Center, Berlin, Germany
Background/Purpose Ustekinumab – a fully human monoclonal antibody against interleukins 12 and 23 – has been shown to be effective in reduction of symptoms of…
Abstract Number: 2617 • 2014 ACR/ARHP Annual Meeting
No Evidence of Accelerated Atheromatosis, Increased Arterial Stiffness or Hypertrophy in Ankylosing Spondylitis: A Systematic Case-Control Study
Aikaterini I. Arida¹, Maria Konsta¹, Alexios Iliopoulos², Maria Tektonidou³, George Konstantonis¹, George D. Kitas⁴, Athanasios D. Protogerou¹ and Petros P. Sfikakis¹, ¹First Department of Propedeutic Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece, ²Department of Rheumatology, Veterans Administration Hospital, Athens, Greece, ³First Department of Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece, ⁴The Dudley Group of Hospitals NHS Foundation Trust, Dudley, and Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom
Background/Purpose: Chronic inflammatory arthritis is associated with increased cardiovascular disease (CVD) risk. The mechanisms behind this link include chronic inflammation, comorbidities and disease-related drugs. CV…
Abstract Number: 2616 • 2014 ACR/ARHP Annual Meeting
Comparison of Characteristics of Ankylosing Spondylitis in Association with Familial Mediterranean Fever with Those of Typical Ankylosing Spondylitis
Dilek Solmaz¹, Servet Akar², Bunyamin Kisacik³, Sule Apras⁴, Soner Senel⁵, Ahmet Mesut Onat³, Timucin Kasifoglu⁶, Kenan Aksu⁷, Ismail Sari⁸, Mehmet Akif Ozturk⁹, Mehmet Sayarlioglu¹⁰, Ali Akdogan⁴, Pinar Cetin⁸ and Nurullah Akkoc⁸, ¹Department of Internal Medicine, Division of Rheumatology, Namik Kemal University School of Medicine, Tekirdag, Turkey, ²Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, ³Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁴Rheumatology, HacettepeUniversity School of Medicine, Ankara, Turkey, ⁵Rheumatology, Kayseri Erciyes University School of Medicine, Kayseri, Turkey, ⁶Rheumatology, Eskisehir OsmangaziUniversity School of Medicine, Eskisehir, Turkey, ⁷Rheumatology, Ege University School of Medicine, Izmir, Turkey, ⁸Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, ⁹Rheumatology, GaziUniversity School of Medicine, Ankara, Turkey, ¹⁰Rheumatology, KahramanmarasSutçü ImamUniversity School of Medicine, Kahramanmaras, Turkey
Background/Purpose Several case reports and a few published studies suggest a link between Familial Mediterranean Fever (FMF) and ankylosing spondylitis (AS). There is very limited…
Abstract Number: 2615 • 2014 ACR/ARHP Annual Meeting
Preliminary Assessment of a Multi-Biomarker Disease Activity Test for Axial Spondyloarthritis
Walter P. Maksymowych¹, Stephanie Wichuk¹, P. Scott Eastman² and Eric H. Sasso³, ¹Department of Medicine, University of Alberta, Edmonton, AB, Canada, ²Crescendo Bioscience, Inc., South San Francisco, CA, ³Crescendo Bioscience Inc., South San Francisco, CA
Background/Purpose There has been limited validation of soluble biomarker measures of disease activity in patients with axial spondyloarthritis (SpA). C-reactive protein (CRP) is most commonly…
Abstract Number: 2614 • 2014 ACR/ARHP Annual Meeting
Reliability of Electronic Patient Self-Assessment of Swollen and Tender Joints in Psoriatic Arthritis: A Comparison Study with B-Mode Ultrasonography, Physician and Nurse Assessments
Agnes Szentpetery¹, Muhammad Haroon², Eileen O'Flynn¹, Phil Gallagher¹, Shafeeq Alraqi¹ and Oliver FitzGerald¹, ¹Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, ²Newmarket On Fergus, Cork University Hospital, Cork, Ireland
Background/Purpose 68 tender (TJC) and 66 swollen joint counts (SJC) are recommended for disease activity assessment in psoriatic arthritis (PsA). However there are time constraints…
Abstract Number: 2633 • 2014 ACR/ARHP Annual Meeting
Factors Associated with Damage Accrual and Survival in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Prospective Cohort Analysis of 747 Patients
Chi Chiu Mok¹, Sau Mei Tse¹, Ling Yin Ho¹ and Chi Hung To², ¹Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, ²Flat D 20 /F Block 1, Chelsea Heights, Hong Kong, Hong Kong
Background/Purpose To evaluate the factors associated with accrual of organ damage in a longitudinal cohort of Chinese patients with SLEMethods A longitudinal cohort of 747…
Abstract Number: 2632 • 2014 ACR/ARHP Annual Meeting
The Cornerstone to Reasonable Allocation of Health Resource: Valuation of Health Utility in Systemic Lupus Erythematosus
Suli Wang and Liangjing Lu, Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Background/Purpose: In a time of increasing economic constraints, it is crucial that health systems optimize their resource use to ensure that they generate the maximum…
Abstract Number: 2631 • 2014 ACR/ARHP Annual Meeting
Overall Cause and Cause-Specific Mortality in a Multinational Inception Cohort of SLE
Murray B. Urowitz¹, Dafna D. Gladman¹, Nicole Anderson², Dominique Ibanez³ and Systemic Lupus International Collaborating Clinics (SLICC)⁴, ¹University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, Toronto Western Hospital Research Institute, Toronto, ON, Canada, ³Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Toronto Western Hospital, Division of Rheumatology, University of Toronto, Toronto Western Hospital (Coordinating Center), Toronto, ON, Canada
Background/Purpose: A large multicenter multinational inception cohort was established initially to study risk factors for atherosclerosis (AS) in SLE. The aim of this study was…
Abstract Number: 2630 • 2014 ACR/ARHP Annual Meeting
An Evaluation of Quality of Life of Patients with Systemic Lupus Erythematosus Attending Rheumatology Clinic in Kenyatta National Hospital, Nairobi, Kenya
Jackline Odhiambo, internal medicine, university of nairobi, nairobi, Kenya
Background/Purpose Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that affects all organs of the body. Due to its chronicity SLE has been known…
Abstract Number: 2629 • 2014 ACR/ARHP Annual Meeting
Childhood-Onset and Adult-Onset Systemic Lupus Erythematosus: Distinctions in an Underserved Ethnic Minority Cohort
Rebekah Neal¹, Kimberly DeQuattro², Elizabeth C. Ortiz¹ and Francisco P. Quismorio Jr. ³, ¹Rheumatology, University of Southern California, Los Angeles, CA, ²LAC+USC Medical Center, Los Angeles, CA, ³Div of Rheum & Immun, Keck School of Medicine, University of Southern California, Los Angeles, CA
Background/Purpose: Previous studies suggest differences between childhood-onset SLE (cSLE) and adult onset SLE (aSLE). Whereas the prevalence of nephritis, neuropsychiatric, dermatologic, and hematologic manifestations are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].